Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP687537.RAu5QQsvdQAjpS2mHqdYASsx7RbwBoFYuqsw-L1CAa1Y8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP687537.RAu5QQsvdQAjpS2mHqdYASsx7RbwBoFYuqsw-L1CAa1Y8130_assertion type Assertion NP687537.RAu5QQsvdQAjpS2mHqdYASsx7RbwBoFYuqsw-L1CAa1Y8130_head.
- NP687537.RAu5QQsvdQAjpS2mHqdYASsx7RbwBoFYuqsw-L1CAa1Y8130_assertion description "[The p53 signature and its malignant counterpart (TIC) underline the significance of the fimbria, both as a candidate site for serous carcinogenesis and as a target for future research on the early detection and prevention of this disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP687537.RAu5QQsvdQAjpS2mHqdYASsx7RbwBoFYuqsw-L1CAa1Y8130_provenance.
- NP687537.RAu5QQsvdQAjpS2mHqdYASsx7RbwBoFYuqsw-L1CAa1Y8130_assertion evidence source_evidence_literature NP687537.RAu5QQsvdQAjpS2mHqdYASsx7RbwBoFYuqsw-L1CAa1Y8130_provenance.
- NP687537.RAu5QQsvdQAjpS2mHqdYASsx7RbwBoFYuqsw-L1CAa1Y8130_assertion SIO_000772 17117391 NP687537.RAu5QQsvdQAjpS2mHqdYASsx7RbwBoFYuqsw-L1CAa1Y8130_provenance.
- NP687537.RAu5QQsvdQAjpS2mHqdYASsx7RbwBoFYuqsw-L1CAa1Y8130_assertion wasDerivedFrom befree-20140225 NP687537.RAu5QQsvdQAjpS2mHqdYASsx7RbwBoFYuqsw-L1CAa1Y8130_provenance.
- NP687537.RAu5QQsvdQAjpS2mHqdYASsx7RbwBoFYuqsw-L1CAa1Y8130_assertion wasGeneratedBy ECO_0000203 NP687537.RAu5QQsvdQAjpS2mHqdYASsx7RbwBoFYuqsw-L1CAa1Y8130_provenance.